Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,473.47
(
0.37%
)
US TECH 100
28,612.40
(
0.11%
)
Dow Jones
50,579.70
(
0.58%
)
Brent Oil
95.20
(
-5.90%
)
Bitcoin
76,568.99
(
-0.91%
)
News Focus
News Focus
Post# of 257628
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 123010
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: ciotera post# 228007

Monday, 01/06/2020 5:31:24 PM

Monday, January 06, 2020 5:31:24 PM

Post# of 257628
MRK—As “failures” go, OS HR=0.80—[95% CI 0.64-0.98]—in KEYNOTE-604 is not such a bad result.

Meeting the PFS endpoint in KEYNOTE-604 (with HR=0.75) and being approved in third-line SCLC (#msg-149450826) ought to allow Keytruda to garner some meaningful business in SCLC, despite Tecentriq’s nominally better outcome in the first-line setting.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today